Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1641 1644
This examiner grants 62% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18249991 | NATURAL KILLER CELLS WITH ENHANCED ACTIVITY | Non-Final OA | The Regents of the University of California |
| 18048386 | THERAPIES AND METHODS TO TREAT TLR2-MEDIATED DISEASES AND DISORDERS | Final Rejection | The Regents of the University of California |
| 18242868 | FACTOR X BINDERS ENHANCING FX ACTIVATION | Final Rejection | Novo Nordisk A/S |
| 18060215 | COMPOSITIONS AND METHODS FOR PURIFYING ALPHA-1 ANTITRYPSIN USING PEPTIDE LIGANDS | Non-Final OA | North Carolina State University |
| 19230637 | ANTICOAGULANT PROTEINS AND THEIR USE FOR TREATING DISEASES ASSOCIATED WITH THE ACTIVATION OF NEUTROPHILS | Non-Final OA | BIOXODES |
| 17868422 | SYSTEMS AND METHODS FOR MONITORING PLATELET ACTIVATION | Final Rejection | The Regents of the University of Michigan |
| 18034999 | CHIMERIC ANTIGEN RECEPTOR | Non-Final OA | National University Corporation Tokai National Higher Education and Research System |
| 16646577 | MULTICELLULAR TARGETING LIPOSOME | Non-Final OA | SHANGHAI JIAO TONG UNIVERSITY |
| 18018936 | DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATING HEMATOPOIETIC STEM CELL TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY (HSCT-TMA) | Non-Final OA | Alexion Pharmaceuticals, Inc. |
| 17784025 | METHODS OF TREATING PREGNANCY-ASSOCIATED ATYPICAL HEMOLYTIC UREMIC SYNDROME USING AN ANTI-C5 ANTIBODY | Non-Final OA | Alexion Pharmaceuticals, Inc. |
| 18250106 | COMBINATION VACCINE FOR PROTECTING SWINE AGAINST VARIOUS DISORDERS | Non-Final OA | Intervet Inc. |
| 18030901 | THERAPEUTIC AGENT FOR IMMUNE/INFLAMMATORY DISEASE | Non-Final OA | Takeda Pharmaceutical Company Limited |
| 17284291 | METHOD FOR PRODUCING ANTIBODY-DRUG CONJUGATE | Final Rejection | TAKEDA PHARMACEUTICAL COMPANY LIMITED |
| 18452155 | METHODS FOR PREVENTING OR TREATING ALLERGY BY ADMINISTERING AN IL-4R ANTAGONIST | Final Rejection | SANOFI BIOTECHNOLOGY |
| 18148888 | COMPOSITIONS AND METHODS FOR TREATING ALLOGRAFT VASCULOPATHY, MOYAMOYA DISEASE, MOYAMOYA SYNDROME AND INTIMAL PROLIFERATION | Non-Final OA | Westfälische Wilhelms-Universität Münster |
| 18246423 | Recombinant Fusion Proteins Comprising Interleukin-18-Binding Protein and Antigen Binding Fragment to Serum Albumin, and Compositions and Uses Thereof | Non-Final OA | Aprilbio Co., Ltd. |
| 18022096 | Fusion proteins for the diagnosis, prophylaxis and treatment of infectious diseases | Non-Final OA | Vitruviae LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy